Adaptive immunity and atherosclerosis.

[1]  S. Akira,et al.  Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet. , 2009, Molecular immunology.

[2]  D. Ramji,et al.  Interferon gamma: a master regulator of atherosclerosis. , 2009, Cytokine & growth factor reviews.

[3]  A. Hamsten,et al.  Genetic variants of TNFSF4 and risk for carotid artery disease and stroke , 2009, Journal of Molecular Medicine.

[4]  J. Pober,et al.  Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery–Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells , 2009, Circulation.

[5]  C. Sommer,et al.  Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke , 2009, Nature Medicine.

[6]  A. Sharpe,et al.  T-Cell Costimulation and Coinhibition in Atherosclerosis , 2008, Circulation research.

[7]  V. Kuchroo,et al.  Interleukin 4 inhibits TGF-β-induced-Foxp3+T cells and generates, in combination with TGF-β, Foxp3− effector T cells that produce interleukins 9 and 10 , 2008, Nature Immunology.

[8]  P. Openshaw.  Faculty Opinions recommendation of Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. , 2008 .

[9]  P. Libby,et al.  The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models , 2008, Nature Reviews Immunology.

[10]  Ohad Parnes,et al.  Inflammation , 2008, The Lancet.

[11]  Anna Huttenlocher,et al.  Reverse leukocyte migration can be attractive or repulsive. , 2008, Trends in cell biology.

[12]  P. Libby,et al.  Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. , 2008, The American journal of pathology.

[13]  P. Libby.  The molecular mechanisms of the thrombotic complications of atherosclerosis , 2008, Journal of internal medicine.

[14]  Y. Allanore,et al.  Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs , 2008, Expert opinion on pharmacotherapy.

[15]  G. Keren,et al.  The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. , 2008, Atherosclerosis.

[16]  Lieping Chen,et al.  CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice , 2008, Circulation.

[17]  W. Kuziel,et al.  CC chemokine receptor 5 influences late-stage atherosclerosis. , 2007, Atherosclerosis.

[18]  A. Sharpe,et al.  Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. , 2007, The Journal of clinical investigation.

[19]  C. Weber,et al.  Transmembrane chemokines: Versatile ‘special agents’ in vascular inflammation , 2007, Thrombosis and Haemostasis.

[20]  T. V. van Berkel,et al.  Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) Pathway Attenuates Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[21]  A. Sharpe,et al.  Impaired Regulatory T-Cell Response and Enhanced Atherosclerosis in the Absence of Inducible Costimulatory Molecule , 2006, Circulation.

[22]  E. Shevach,et al.  The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells , 2006, Immunological reviews.

[23]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[24]  K. Moore,et al.  Chemokine CXCL10 Promotes Atherogenesis by Modulating the Local Balance of Effector and Regulatory T Cells , 2006, Circulation.

[25]  Kayoko Sato,et al.  T Cell Recognition and Killing of Vascular Smooth Muscle Cells in Acute Coronary Syndrome , 2006, Circulation research.

[26]  G. Hansson,et al.  Adoptive Transfer of CD4+ T Cells Reactive to Modified Low-Density Lipoprotein Aggravates Atherosclerosis , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[27]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[28]  M. Chiariello,et al.  Patients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable Plaque: Evidence for a Local, Intracoronary Immunologic Mechanism , 2006, Circulation.

[29]  R. Flavell,et al.  Natural regulatory T cells control the development of atherosclerosis in mice , 2006, Nature Medicine.

[30]  H. Spring,et al.  Chemokines direct endothelial progenitors into tumor neovessels. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Beckers,et al.  Leukocyte CD40L deficiency affects the CD25(+) CD4 T cell population but does not affect atherosclerosis. , 2005, Atherosclerosis.

[32]  Graham M Lord,et al.  T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. , 2005, Blood.

[33]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[34]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[35]  S. Zuckerman,et al.  Gamma interferon: a central mediator in atherosclerosis , 2005, Inflammation Research.

[36]  Y. Bobryshev.  Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. , 2005, European heart journal.

[37]  F. Mach,et al.  Differential Influence of Chemokine Receptors CCR2 and CXCR3 in Development of Atherosclerosis In Vivo , 2005, Circulation.

[38]  F. Zipp,et al.  Atorvastatin Induces T Cell Anergy via Phosphorylation of ERK11 , 2005, The Journal of Immunology.

[39]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[40]  Xinghua Zhou,et al.  IL-18 Accelerates Atherosclerosis Accompanied by Elevation of IFN-&ggr; and CXCL16 Expression Independently of T Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[41]  R. Coffman,et al.  T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[42]  Per Eriksson,et al.  Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility , 2005, Nature Genetics.

[43]  M. Rudling,et al.  Lesion Development and Response to Immunization Reveal a Complex Role for CD4 in Atherosclerosis , 2005, Circulation research.

[44]  P. Adamson,et al.  Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction1 , 2005, The Journal of Immunology.

[45]  L. Glimcher,et al.  T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[47]  F. Mach,et al.  Differential Expression Patterns of Proinflammatory and Antiinflammatory Mediators During Atherogenesis in Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[48]  J. Arnal,et al.  Deleting TCRαβ+ or CD4+ T Lymphocytes Leads to Opposite Effects on Site-Specific Atherosclerosis in Female Apolipoprotein E-Deficient Mice , 2004 .

[49]  C. Schindler,et al.  IL-6 and the acute phase response in murine atherosclerosis. , 2004, Atherosclerosis.

[50]  Yuzhi Zhang,et al.  Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L. Hovgaard,et al.  Inhibition of Tumor Necrosis Factor-&agr; Reduces Atherosclerosis in Apolipoprotein E Knockout Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[52]  D. Broide,et al.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. , 2004, The Journal of clinical investigation.

[53]  A. Tedgui,et al.  Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[54]  Richard T. Lee,et al.  Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. , 2004, The Journal of clinical investigation.

[55]  V. Durkalski,et al.  Oral simvastatin treatment in relapsing-remitting multiple sclerosis , 2004, The Lancet.

[56]  A. Lichtman,et al.  Co-stimulation and plaque-antigen-specific T-cell responses in atherosclerosis. , 2004, Trends in cardiovascular medicine.

[57]  K. Okumura,et al.  Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  A. Vallejo,et al.  T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. , 2004, Trends in molecular medicine.

[59]  H. Ljunggren,et al.  CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis , 2004, The Journal of experimental medicine.

[60]  R. Flavell,et al.  Disruption of TGF-β signaling in T cells accelerates atherosclerosis , 2003 .

[61]  P. Kovanen,et al.  Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells--a potential mechanism for the weakening and rupture of atherosclerotic plaques. , 2003, Biochemical pharmacology.

[62]  A. Tedgui,et al.  Induction of a Regulatory T Cell Type 1 Response Reduces the Development of Atherosclerosis in Apolipoprotein E–Knockout Mice , 2003, Circulation.

[63]  P. Tipping,et al.  The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. , 2003, The American journal of pathology.

[64]  S. Akira,et al.  Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. , 2003, Cardiovascular research.

[65]  R. Pedrosa,et al.  Therapeutic potential of lovastatin in multiple sclerosis , 2003, Journal of Neurology.

[66]  R. Callard,et al.  CD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet Activation , 2003, Circulation research.

[67]  B. Machaliński,et al.  The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis , 2003, Arthritis research & therapy.

[68]  P. Adamson,et al.  Lovastatin inhibits brain endothelial cell Rho‐mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  C. Come,et al.  Influence of Interferon-&ggr; on the Extent and Phenotype of Diet-Induced Atherosclerosis in the LDLR-Deficient Mouse , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[70]  Christine A. Lee,et al.  NKT cell subsets in infection and inflammation. , 2003, Immunology letters.

[71]  Peter Libby,et al.  Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. , 2002, JAMA.

[72]  S. Youssef,et al.  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease , 2002, Nature.

[73]  M. Gawaz,et al.  A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation , 2002, The Journal of experimental medicine.

[74]  L. Miller.  Cardiovascular Toxicities of Immunosuppressive Agents , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[75]  J. Borén,et al.  Subendothelial retention of atherogenic lipoproteins in early atherosclerosis , 2002, Nature.

[76]  A. Daugherty,et al.  IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[77]  M. Fishbein,et al.  Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes , 2002, Circulation research.

[78]  G. Hansson,et al.  Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.

[79]  A. Daugherty,et al.  Interleukin-4 Deficiency Decreases Atherosclerotic Lesion Formation in a Site-Specific Manner in Female LDL Receptor−/− Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[80]  A. Daugherty,et al.  Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E−/− Mice Through Release of Interferon-&ggr; , 2002, Circulation research.

[81]  James L. Young,et al.  Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages , 2002, The Journal of experimental medicine.

[82]  P. Libby,et al.  CD40 Signaling and Plaque Instability , 2001, Circulation research.

[83]  A. Tedgui,et al.  Inhibition of Transforming Growth Factor-&bgr; Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice , 2001, Circulation research.

[84]  A. Tedgui,et al.  Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability , 2001, Circulation.

[85]  A. Tedgui,et al.  Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability , 2001, Circulation research.

[86]  C. Schindler,et al.  Lymphocytes are important in early atherosclerosis. , 2001, The Journal of clinical investigation.

[87]  J. Bluestone,et al.  Effect of Immune Deficiency on Lipoproteins and Atherosclerosis in Male Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[88]  Joerg Kallen,et al.  Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site , 2001, Nature Medicine.

[89]  M. Newell,et al.  T Helper—Cell Phenotype Regulates Atherosclerosis in Mice Under Conditions of Mild Hypercholesterolemia , 2001, Circulation.

[90]  Xinghua Zhou,et al.  Transfer of CD4+ T Cells Aggravates Atherosclerosis in Immunodeficient Apolipoprotein E Knockout Mice , 2000, Circulation.

[91]  P. Loetscher,et al.  Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function , 2000, The Journal of experimental medicine.

[92]  E. Kremmer,et al.  Follicular B Helper T Cells Express Cxc Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production , 2000, The Journal of experimental medicine.

[93]  F. Mach,et al.  Statins as a newly recognized type of immunomodulator , 2000, Nature Medicine.

[94]  A. Daugherty,et al.  Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice , 2000 .

[95]  M. Kurrer,et al.  Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[96]  F. Romero,et al.  Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit. , 2000, Atherosclerosis.

[97]  Qingbo Xu,et al.  Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. , 2000, Circulation.

[98]  R. Frye,et al.  Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. , 2000, Circulation.

[99]  P. Libby,et al.  Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[100]  M. Daemen,et al.  Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[101]  J. Farmer.  Pleiotropic effects of statins , 2000, Current atherosclerosis reports.

[102]  J. Witztum,et al.  Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis , 2000, Journal of internal medicine.

[103]  J. Pober,et al.  Interferon-γ elicits arteriosclerosis in the absence of leukocytes , 2000, Nature.

[104]  M. Territo,et al.  Interleukin-10 blocks atherosclerotic events in vitro and in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[105]  M. Daemen,et al.  Requirement for CD154 in the progression of atherosclerosis , 1999, Nature Medicine.

[106]  M. Bureau,et al.  Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.

[107]  Qingbo Xu,et al.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study. , 1999, Circulation.

[108]  P. Libby,et al.  CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. , 1999, The American journal of pathology.

[109]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[110]  Y. Shoenfeld,et al.  Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[111]  Tzong-Shyuan Lee,et al.  The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[112]  Y. Shoenfeld,et al.  Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. , 1998, Circulation.

[113]  V. Tkachuk,et al.  Density‐ and proliferation status‐dependent expression of T‐cadherin, a novel lipoprotein‐binding glycoprotein: a function in negative regulation of smooth muscle cell growth? , 1998, FEBS letters.

[114]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[115]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[116]  P. Libby,et al.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.

[117]  R. Ross,et al.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[118]  Y. Bobryshev,et al.  Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. , 1998, Cardiovascular research.

[119]  Reinhold Förster,et al.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.

[120]  W. Erl,et al.  HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. , 1997, Journal of the American College of Cardiology.

[121]  L. Berglund,et al.  Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[122]  A Daugherty,et al.  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. , 1997, The Journal of clinical investigation.

[123]  A. Becker,et al.  Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. , 1997, Atherosclerosis.

[124]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[125]  J. D. Smith,et al.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[126]  C. Bell,et al.  Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. , 1996, The American journal of pathology.

[127]  A. Daugherty,et al.  Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[128]  L. Demer,et al.  Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. , 1996, The Journal of clinical investigation.

[129]  B. Kasiske,et al.  Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? , 1996, The Lancet.

[130]  S. Young,et al.  Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[131]  G. Schonfeld,et al.  Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. , 1995, The Journal of clinical investigation.

[132]  Michael Ginsberg,et al.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[133]  P. Tipping,et al.  Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit. , 1995, Atherosclerosis.

[134]  J. Pober,et al.  CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[135]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[136]  P. Libby,et al.  Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. , 1995, Journal of immunology.

[137]  E. Emeson,et al.  Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. , 1993, The American journal of pathology.

[138]  Qingbo Xu,et al.  Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. , 1993, The American journal of pathology.

[139]  Qingbo Xu,et al.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.

[140]  A. Gown,et al.  Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[141]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[142]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[143]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[144]  G. Gabbiani,et al.  Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells , 1989, The Journal of experimental medicine.

[145]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.

[146]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[147]  中谷 矩章.  HMG-CoA Reductase Inhibitor , 1988 .

[148]  G. Hansson,et al.  Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[149]  L. Jonasson,et al.  Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. , 1986, Clinical and experimental immunology.

[150]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[151]  G. Gabbiani,et al.  Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. , 1985, The Journal of clinical investigation.

[152]  F. Fourrier,et al.  Infections , 2011, Laboratory Investigation.

[153]  Christian Weber,et al.  Chemokines in Atherosclerosis , Thrombosis , and Vascular Biology Series Editor : Christian Weber Chemokines in Atherosclerosis An Update , 2008 .

[154]  J. Kuiper,et al.  Interruption of the Tnfrsf 4 / Tnfsf 4 ( OX 40 / OX 40 L ) Pathway Attenuates Atherogenesis in Low-Density Lipoprotein Receptor – Deficient Mice , 2006 .

[155]  D. Ramji,et al.  Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? , 2005, Cardiovascular research.

[156]  D. Ramji,et al.  Interferon-g and atherosclerosis : Pro-or anti-atherogenic ? , 2005 .

[157]  C. Benoist,et al.  CD4 CD25 T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion , 2004 .

[158]  M. Seishima,et al.  Interferon-gamma produced by bone marrow-derived cells attenuates atherosclerotic lesion formation in LDLR-deficient mice. , 2004, Journal of atherosclerosis and thrombosis.

[159]  W. Daniel,et al.  HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. , 2004, Atherosclerosis.

[160]  J. Arnal,et al.  Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. , 2004, The American journal of pathology.

[161]  J. Michel,et al.  Interleukin-10 Deficiency Increases Atherosclerosis, Thrombosis, and Low-density Lipoproteins in Apolipoprotein E Knockout Mice , 2003, Molecular medicine.

[162]  R. Flavell,et al.  Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. , 2003, The Journal of clinical investigation.

[163]  R. Madhok,et al.  A Novel Anti-Inflammatory Role for Simvastatin in Inflammatory Arthritis , 2003 .

[164]  M. Daemen,et al.  Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[165]  G. Hansson,et al.  Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[166]  J. Pober,et al.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. , 2000, Nature.

[167]  A. Daugherty,et al.  Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. , 2000, The American journal of pathology.

[168]  E. Dennis,et al.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.

[169]  I. Barshack,et al.  Immunolocalization of b2-Glycoprotein I (Apolipoprotein H) to Human Atherosclerotic Plaques Potential Implications for Lesion Progression , 1999 .

[170]  J. D. Smith,et al.  Mouse models of atherosclerosis. , 1998, Laboratory animal science.

[171]  A. Grace,et al.  The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis , 1995, Nature Medicine.

[172]  Transforming Growth Factor-β Mediates Balance Between Inflammation and Fibrosis During Plaque Progression , 2022 .